Page last updated: 2024-08-23

staurosporine and Long QT Syndrome

staurosporine has been researched along with Long QT Syndrome in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Addo, MF; Andrade-Gordon, P; Cheung, WM; Conway, BR; Croll, D; Damiano, BP; Demarest, KT; Derian, CK; Eckardt, AJ; Emanuel, S; Hecker, LR; Li, J; Li, Q; Maryanoff, BE; McComsey, DF; Smith, CE; White, KB; Ye, H; Zhang, HC1
Ballesta-López, O; Martínez-Cuadrón, D; Megías-Vericat, JE; Montesinos, P; Solana-Altabella, A1
del Corral, A; Dutreix, C; Harrell, R; Huntsman-Labed, A; Lorenzo, S; Morganroth, J; Wang, Y1

Reviews

1 review(s) available for staurosporine and Long QT Syndrome

ArticleYear
Drug-drug interactions of newly approved small molecule inhibitors for acute myeloid leukemia.
    Annals of hematology, 2020, Volume: 99, Issue:9

    Topics: Antineoplastic Agents; Benzimidazoles; Bridged Bicyclo Compounds, Heterocyclic; Cytochrome P-450 CYP3A Inhibitors; Drug Approval; Drug Interactions; Drugs, Investigational; Humans; Leukemia, Myeloid, Acute; Long QT Syndrome; Phenylurea Compounds; Protein Kinase Inhibitors; Staurosporine; Sulfonamides

2020

Trials

1 trial(s) available for staurosporine and Long QT Syndrome

ArticleYear
Midostaurin does not prolong cardiac repolarization defined in a thorough electrocardiogram trial in healthy volunteers.
    Cancer chemotherapy and pharmacology, 2012, Volume: 69, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Agents; Aza Compounds; Double-Blind Method; Electrocardiography; Female; Fluoroquinolones; Heart Rate; Humans; Long QT Syndrome; Male; Middle Aged; Moxifloxacin; Protein Kinase Inhibitors; Quinolines; Staurosporine; Young Adult

2012

Other Studies

1 other study(ies) available for staurosporine and Long QT Syndrome

ArticleYear
Novel indolylindazolylmaleimides as inhibitors of protein kinase C-beta: synthesis, biological activity, and cardiovascular safety.
    Journal of medicinal chemistry, 2005, Mar-24, Volume: 48, Issue:6

    Topics: Animals; Cell Line; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Guinea Pigs; Humans; Indazoles; Indoles; Interleukin-8; Isoenzymes; Long QT Syndrome; Maleimides; Models, Molecular; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Protein Kinase C; Protein Kinase C beta; Structure-Activity Relationship

2005